advertisement
advertisement

This super cheap cancer risk test is going global

Color Genomics, a genetics company founded by a couple of Twitter veterans, is bringing its DNA test global. Color’s $249 test for breast and ovarian cancer risk is among the cheapest on the market, making it an attractive option for those who would prefer to pay out-of-pocket. The test is now available in more than … Continue reading “This super cheap cancer risk test is going global”

Color Genomics, a genetics company founded by a couple of Twitter veterans, is bringing its DNA test global. Color’s $249 test for breast and ovarian cancer risk is among the cheapest on the market, making it an attractive option for those who would prefer to pay out-of-pocket. The test is now available in more than 100 countries, including the U.K. and Australia, and most states in the U.S., with the (surprising) exception of New York.

advertisement
advertisement

About the author

Christina Farr is a San Francisco-based journalist specializing in health and technology. Before joining Fast Company, Christina worked as a reporter for VentureBeat, Reuters and KQED

More